Reply:
Shujuan Pan, Richard N. Sifers – 28 September 2009
Reply:
Jordi Rimola, Alejandro Forner, Carmen Ayuso, Jordi Bruix, BCLC Group – 28 September 2009
Zinc supplementation reverses alcohol‐induced steatosis in mice through reactivating hepatocyte nuclear factor‐4α and peroxisome proliferator‐activated receptor‐α
Xinqin Kang, Wei Zhong, Jie Liu, Zhenyuan Song, Craig J. McClain, Y. James Kang, Zhanxiang Zhou – 28 September 2009 – Alcoholic steatosis is a fundamental metabolic disorder in the progression of alcoholic liver disease. Zinc deficiency is one of the most consistently observed biochemical/nutritional manifestations of alcoholic liver disease. The purpose of this study is to determine whether dietary zinc supplementation to mice previously exposed to alcohol could reverse alcoholic steatosis.
Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice
Kang Cheng, Daniel Benten, Kuldeep Bhargava, Mari Inada, Brigid Joseph, Christopher Palestro, Sanjeev Gupta – 28 September 2009 – Tracking stem/progenitor cells through noninvasive imaging is a helpful means of assessing the targeting of transplanted cells to specific organs. We performed in vitro and in vivo studies wherein adult human hepatocytes and human fetal liver stem/progenitor cells were labeled with indium‐111 (111In)‐oxine and technetium‐99m (99mTc)‐Ultratag or 99mTc‐Ceretec.
Hepatitis C drug development at a crossroads
David R. Nelson – 28 September 2009
Role of cholesterol determination in ascitic fluid analysis
Alexander L. Gerbes, Dieter Jüngst – 28 September 2009
Mcl‐1 and Bcl‐xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver
Hayato Hikita, Tetsuo Takehara, Satoshi Shimizu, Takahiro Kodama, Wei Li, Takuya Miyagi, Atsushi Hosui, Hisashi Ishida, Kazuyoshi Ohkawa, Tatsuya Kanto, Naoki Hiramatsu, Xiao‐Ming Yin, Lothar Hennighausen, Tomohide Tatsumi, Norio Hayashi – 28 September 2009 – Anti‐apoptotic members of the Bcl‐2 family, including Bcl‐2, Bcl‐xL, Mcl‐1, Bcl‐w and Bfl‐1, inhibit the mitochondrial pathway of apoptosis. Bcl‐xL and Mcl‐1 are constitutively expressed in the liver.
Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Johannes Wiegand, Keyur Patel, Hans L. Tillmann – 28 September 2009
Reply:
Maurizia R. Brunetto – 28 September 2009
Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo‐angiogenesis regulation
Antonio Mazzocca, Emilia Fransvea, Gabriela Lavezzari, Salvatore Antonaci, Gianluigi Giannelli – 28 September 2009 – Curative therapies for patients with hepatocellular carcinoma (HCC) are mainly invasive, and with the exception of sorafenib, no medical treatments are available for advanced or metastatic stages of HCC. We investigated the antitumoral effect of blocking the transforming growth factor β (TGF‐β) signaling pathway in HCC with LY2109761, a kinase inhibitor of TGF‐β receptor I kinase.